Acadia Healthcare (NASDAQ:ACHC) Releases Earnings Results

Acadia Healthcare (NASDAQ:ACHC) issued its quarterly earnings data on Tuesday. The company reported $0.38 EPS for the quarter, beating the consensus estimate of $0.35 by $0.03, Zacks reports. The firm had revenue of $865.84 million during the quarter, compared to the consensus estimate of $844.19 million. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. Acadia Healthcare updated its FY 2026 guidance to 1.450-1.600 EPS.

Acadia Healthcare Stock Up 0.6%

Acadia Healthcare stock traded up $0.19 during trading hours on Tuesday, hitting $32.69. 4,345,024 shares of the stock traded hands, compared to its average volume of 3,343,216. Acadia Healthcare has a one year low of $11.43 and a one year high of $35.83. The firm’s 50-day moving average price is $27.78 and its two-hundred day moving average price is $23.36. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.27. The company has a market cap of $3.01 billion, a PE ratio of -2.67, a PEG ratio of 11.51 and a beta of 0.64.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the company. UBS Group boosted their price target on Acadia Healthcare from $31.00 to $39.00 and gave the company a “buy” rating in a report on Thursday, July 9th. Royal Bank Of Canada increased their price objective on Acadia Healthcare from $28.00 to $31.00 and gave the stock an “outperform” rating in a report on Monday, May 4th. Raymond James Financial upgraded Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 price objective on the stock in a research report on Monday, May 4th. Guggenheim upped their target price on Acadia Healthcare from $26.00 to $31.00 and gave the company a “buy” rating in a report on Monday, May 4th. Finally, Barclays raised their price target on Acadia Healthcare from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research note on Thursday, April 30th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have issued a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $28.69.

Institutional Investors Weigh In On Acadia Healthcare

Several hedge funds have recently made changes to their positions in the company. Wells Fargo & Company MN grew its stake in Acadia Healthcare by 208.9% in the fourth quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock worth $32,000 after purchasing an additional 1,510 shares during the period. EverSource Wealth Advisors LLC lifted its position in Acadia Healthcare by 54.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after buying an additional 497 shares during the period. Aristides Capital LLC bought a new stake in shares of Acadia Healthcare during the 4th quarter valued at $196,000. Prudential Financial Inc. grew its position in shares of Acadia Healthcare by 21.9% in the 2nd quarter. Prudential Financial Inc. now owns 9,903 shares of the company’s stock worth $225,000 after buying an additional 1,780 shares during the period. Finally, Glenmede Investment Management LP increased its stake in shares of Acadia Healthcare by 15.6% in the 3rd quarter. Glenmede Investment Management LP now owns 11,379 shares of the company’s stock worth $282,000 after acquiring an additional 1,532 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.